Vireo Growth Inc. (VREOF) — 10-Q Filings

10-Q Filings (6)

• Vireo Growth Revenue Soars 121% Post-Mergers, Net Loss Widens to $47.7M — Nov 12, 2025 Risk: high
  Vireo Growth Inc. (VREOF) reported a significant increase in revenue for the nine months ended September 30, 2025, reaching $164,258,806, up from $74,360,905 in
• Vireo Growth's Revenue Soars 48% Amidst Widening Losses, Major Acquisitions — Aug 13, 2025 Risk: high
  Vireo Growth Inc. (VREOF) reported a significant increase in revenue for the six months ended June 30, 2025, reaching $72,603,651, up from $49,195,562 in the pr
• Vireo Growth Inc. Files Q1 2025 10-Q — May 9, 2025 Risk: medium
  Vireo Growth Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Goodness Growth Holdings, Inc. and Vireo Health Internatio
• Vireo Growth Inc. Files Q3 2024 10-Q — Nov 13, 2024 Risk: medium
  Vireo Growth Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Vireo Health International, Inc., is in the pharmaceut
• Vireo Growth Inc. Files Q2 2024 10-Q — Aug 6, 2024 Risk: medium
  Vireo Growth Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Goodness Growth Holdings, Inc. and Vireo Health Internation
• Goodness Growth Holdings, Inc. Files 10-Q for Period Ending March 31, 2024 — May 7, 2024 Risk: medium
  Goodness Growth Holdings, Inc. (VREOF) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Goodness Growth Holdings, Inc. filed a 10-Q report for the p

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX